Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
05/2005
05/05/2005US20050095199 protecting against parasites and predators; transgenic organisims
05/05/2005US20050095198 Annexin derivatives with endogenous chelation sites
05/05/2005US20050095196 Increasing blood permeability to capillary or arterial cells of abnormal brain region
05/04/2005EP1528103A1 'Osteoclast-inhibitory factor' (OCIF) derived proteins and methods for producing the proteins
05/04/2005EP1528102A2 Cloning and recombinant productions of polistinae venom enzymes, such as phospholipase and hyaluronidase, and immunological therapies based thereon
05/04/2005EP1527787A1 Immediate release tablet
05/04/2005EP1527786A1 Tissue volume reduction
05/04/2005EP1527785A1 Use of G-CSF for treating ischemia
05/04/2005EP1527780A1 Stable solid formulation of enalapril salt and process for preparation thereof
05/04/2005EP1527778A1 Methods of enhancing opiate analgesic potency or detoxifying an opiate addict
05/04/2005EP1527771A2 Aqueous aerosol preparations containing biologically active macromolecules and method for producing the corresponding aerosols
05/04/2005EP1527346A1 Modulation of platelet adhesion based on the surface exposed beta-switch loop of platelet glycoprotein ib-alpha
05/04/2005EP1527345A2 Method for isolating atp binding proteins by means of immobilized protein inhibitors
05/04/2005EP1527340A2 Method for identifying substances
05/04/2005EP1527179A2 Il-7 drug substance, il- 7 comprising composition, preparation and uses thereof
05/04/2005EP1527178A2 Novel class ii cytokine receptors and uses thereof
05/04/2005EP1527176A2 Further novel forms of interfering rna molecules
05/04/2005EP1527169A2 Leech extracts for stents
05/04/2005EP1527096A2 Binding molecules
05/04/2005EP1527094A2 T-cell epitopes in erythropoietin
05/04/2005EP1527088A1 Pegylated t20 polypeptide
05/04/2005EP1527086A1 Compounds binding to p-selectin
05/04/2005EP1527081A1 Glyconjugates comprising carbohydrate epitopes, methods for theirsynthesis, and their use for the treatment or prophylaxis of cancer
05/04/2005EP1526896A1 Antibacterial ester macrocycles
05/04/2005EP1526871A1 Oral administration of calcitonin
05/04/2005EP1526867A2 Use of erythropoietin
05/04/2005EP1526866A2 Drug conjugate comprising an erythropoietin receptor ligand and an anticancer agent
05/04/2005EP1526865A2 Compounds for targeting hepatocytes
05/04/2005EP1526864A2 Prevention and treatment of nonalcoholic fatty liver disease (nafld) by antagonism of the receptor to glucose-dependent insulinotropic polypeptide (gip)
05/04/2005EP1526863A2 Using heat shock proteins to increase immune response
05/04/2005EP1465493A4 Cultured and encapsulated pancreatic stem cells
05/04/2005EP1442022A4 Polyamide modulators of cox2 transcription
05/04/2005EP1377164A4 Erythropoietin ameliorates chemotherapy-induced toxicity in vivo
05/04/2005EP1362062B1 Concatameric immunoadhesion
05/04/2005EP1313503A4 Human tumor necrosis factor receptors tr21 and tr22
05/04/2005EP1297121B1 Purging of cells using viruses
05/04/2005EP1286679B1 Skin treatment preparation
05/04/2005EP1221480B1 Polypeptide humanin inhibiting nerve cell death
05/04/2005EP1218395B1 Antisense modulation of x-linked inhibitor of apoptosis expression
05/04/2005EP1185292B1 Use of interleukin-11 to treat hemorrhagic shock
05/04/2005EP1156782B1 Echinocandin pharmaceutical formulations containing micelle-forming surfactants
05/04/2005EP1139752B1 Methods and compositions for treatment of cell proliferative disorders
05/04/2005EP1086117A4 Cloning and identification of the motilin receptor
05/04/2005EP1065214B1 Novel physiologically active peptides and utilization thereof
05/04/2005EP1053330B1 Identification, production and use of staphylokinase derivatives with reduced immunogenicity and/or reduced clearance
05/04/2005EP1023067B1 The use of inhibitors of the renin-angiotensin system for the treatment of hypoxia or impaired metabolic function
05/04/2005EP1017798B1 Lunasin peptides
05/04/2005EP0935001B1 Novel vegf-like factors
05/04/2005EP0835266B1 Modified/chimeric superantigens and their use
05/04/2005EP0831907A4 Method for treating molluscum contagiosum resulting from hiv infection
05/04/2005EP0672139B1 Novel polypeptides having opioid receptor activity, nucleic acids coding therefor and uses thereof
05/04/2005CN2696636Y Oral minrature grain of insulin
05/04/2005CN1613012A Soluble cd40l (cd154) as a prognostic marker of atherosclerotic diseases
05/04/2005CN1612895A Conjugates comprising an antibody specific for the ED-B domain of fibronectin and their use for the detection and treatment of tumours
05/04/2005CN1612893A VEGF peptides and their use for inhibiting angiogenesis
05/04/2005CN1612892A Novel peptide having angiotensin convertase inhibitory effect
05/04/2005CN1612890A Novel chimeric tnf ligands
05/04/2005CN1612756A Composition and method for treatment of wounds
05/04/2005CN1612752A Aqueous sustained-release formulations of proteins
05/04/2005CN1612750A TACI-immunoglobulin fusion proteins
05/04/2005CN1612748A Remedies for dry eye and diseases associated with dry eye
05/04/2005CN1612747A Use of red blood cell generation promoter in prevention and treatment of heart faiture
05/04/2005CN1612746A Use of HEPCIDIN as a regulator of iron homeostasis
05/04/2005CN1612745A Methods for slowing senescence and treating and preventing diseases associated with senescence
05/04/2005CN1612741A Use of sulfated glycosaminoglycans for establishing effective labor in women
05/04/2005CN1612725A Injectable depot composition
05/04/2005CN1612724A Vascular occlusion solid-phase agent with immobilised platelet binding agent
05/04/2005CN1612723A Local compositions containing enzymes stabilized with inhibitors
05/04/2005CN1612717A Method and apparatus for production of a skin graft and the graft produced thereby
05/04/2005CN1612715A Method, instruments, and kit for autologous transplantation
05/04/2005CN1611605A Method for producing human leukemia inhibitory factor using transgenic plant
05/04/2005CN1611604A Swine alpha-interferon gene synthesis, expression vector establishment and product preparing method
05/04/2005CN1611603A Novel DNA fragment and its inhibition from tumour
05/04/2005CN1611512A Poly peptide for therapeutic antitumour vaccive
05/04/2005CN1611262A Method for preparing medicine with proteinase inhibiting function and its detecting method
05/04/2005CN1611261A Medicinal preparation of muscular amino acids and nucleosides for injection and its preparing method
05/04/2005CN1611260A Combined medicine of adefovir dipivoxil
05/04/2005CN1200105C Homocysteine desulphurase from the protozoan trichomonas vaginalis
05/04/2005CN1200097C Recombinant human epidermal growth factor and its preparing process and medicinal composition
05/04/2005CN1200000C Cyclie somatostatin analogs
05/04/2005CN1199998C Human protein with suppression to cance cell growth and its coding sequence
05/04/2005CN1199996C New human protein having cancer cell growth in hibiting function and its coding sequence
05/04/2005CN1199995C New Human protein having cancer inhibiting function and its coding sequence
05/04/2005CN1199994C New human protein with cancer cell growth inhibiting function and its coding sequence
05/04/2005CN1199993C N-terminal deletion lipocyte complement related protein and its preparation method
05/04/2005CN1199990C Endothelial cell growth resisting engineered protein
05/04/2005CN1199987C Basic monocyclic compounds having NK2 antagonist action, processes for their preparation and formulations containing them
05/04/2005CN1199716C Preparation of therapeutic composition
05/04/2005CN1199696C Multipurpose packages for steroilizing products or prdoucts on be sterilised
05/04/2005CN1199694C Application of composite fat used as stabilizing additive in medicine of digestive enzyme mixture
05/04/2005CN1199690C Thrombosis resisting composition
05/04/2005CN1199689C Hemoglobin polymerizing agent
05/04/2005CN1199688C Growth hormone for ovarian functional cell and its prepn
05/04/2005CN1199687C Method for extracting gonad stimulating hormone from pregnant mare blood
05/04/2005CN1199686C Sustained release compositions, process for producing the same and utilization thereof
05/04/2005CN1199642C Novel medicinal compsns. containing cyclosporin
05/04/2005CN1199567C Hybrid matrix implants and explants
05/03/2005US6888022 Methods and compounds for inhibiting β-amyloid peptide release and/or its synthesis
05/03/2005US6888016 For therapy of insulin resistance; for stimulating the glucose up-take in adipocytes
05/03/2005US6888007 Stable crystal structure; thrombin inhibitor
1 ... 1449 1450 1451 1452 1453 1454 1455 1456 1457 1458 1459 1460 1461 1462 1463 1464 1465 1466 1467 1468 1469 ... 3163